Mauria Udyog (539219)

Score breakdown: P/E: 3/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Low P/E of 5.75 suggests the market is pricing in current earnings cheaply.
• ROE of 49.47% is exceptionally high, though partly due to a thin book value.
• Latest quarter shows a net profit of ₹5 Cr on sales of ₹82 Cr, avoiding a loss.
• Trades near the lower end of its 52-week range (₹7.39–₹20.94), offering potential upside if fundamentals stabilize.

Concerns

• Sales growth is sharply negative at -36.87%, indicating a contracting business.
• Piotroski F-Score of 3/9 signals weak financial health and possible operational stress.
• Zero dividend yield and undisclosed promoter holding reduce transparency and shareholder friendliness.
• P/B of 2.08 means paying a significant premium to book value for a company with declining sales.

AI Analysis

At first glance, Mauria Udyog looks like a value hunter's dream: a P/E of just 5.75 and a ROE of 49.47%. But Graham taught me to look behind the numbers. Sales have tumbled 36.87%, and profits are down 11.48%. A cheap stock can become cheaper if the underlying business keeps shrinking. The Piotroski F-score of 3 out of 9 is a red flag—this is a company with weak financial health, not a hidden gem. I also notice no dividend, and promoter holding is not disclosed. That worries me; I want to know who is at the wheel. Book value is ₹4.50 per share, but I am asked to pay ₹9.34, or 2.08 times book. For that price, I expect durable growth, not a 36% sales decline. The latest quarter does show a net profit of ₹5 Cr on sales of ₹82 Cr, a thin margin of about 6%. That is better than a loss, but it does not compensate for the shrinking top line. The high ROE seems less about a great franchise and more about a small equity base. This may be a cyclical business in a downturn, or a turnaround waiting for proof. I am not yet convinced. In the words of Buffett: 'It's far better to buy a wonderful company at a fair price than a fair company at a wonderful price.' Mauria Udyog is a fair company, and the price is not wonderful enough. I will keep it on my watchlist, but I will not act until I see evidence of stable sales and honest disclosure.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer